In June, Sadr ul Shaheed presented his research, which used QUOD Biobank samples, at the 74th Annual Conference on Mass Spectrometry and Allied Topics (ASMS 2026) in San Diego, USA.
“[It was] great to be at ASMS2026 sharing our latest work on multi-omics integration in transplantation research.
Our study (RAP052) combined proteomics and metabolomics to investigate donor-derived molecular signatures associated with kidney graft viability and primary non-function, highlighting the potential of integrated omics approaches for biomarker discovery and improved pre-transplant assessment.
It was encouraging to see strong interest from the mass spectrometry community, particularly around multi-omics data integration, translational biomarker research, and the importance of well-characterised biobanking resources in enabling high-impact clinical studies.
Thank you to everyone who took the time to discuss the work and share their insights. Looking forward to future collaborations and advancing the application of multi-omics in precision transplantation.”